POINT BIOPHARMA GLOBAL INC. Proceeds from Stock Options Exercised
POINT BIOPHARMA GLOBAL INC. reported Proceeds from Stock Options Exercised of $331.92 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-11-13
- POINT BIOPHARMA GLOBAL INC. proceeds from stock options exercised for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- POINT BIOPHARMA GLOBAL INC. proceeds from stock options exercised for the quarter ending 2023-06-30 was $186.06K, a 5275.85% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. proceeds from stock options exercised for the quarter ending 2023-03-31 was $145.86K, a 15384.50% increase year-over-year.
- POINT BIOPHARMA GLOBAL INC. proceeds from stock options exercised for the quarter ending 2022-12-31 was $6.95K.
- POINT BIOPHARMA GLOBAL INC. proceeds from stock options exercised for fiscal 2022 was $53.05K, a 88.21% decline from fiscal 2021.
- POINT BIOPHARMA GLOBAL INC. proceeds from stock options exercised for fiscal 2021 was $450.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $186.06K derived: sum of 2 quarters · filed 2023-11-13 | $331.92K 10-Q · filed 2023-11-13 | $338.87K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $186.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $331.92K 10-Q · filed 2023-08-14 | $338.87K derived: sum of 3 quarters · filed 2023-08-14 | $380.57K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $145.86K 10-Q · filed 2023-05-15 | $152.81K derived: sum of 2 quarters · filed 2023-05-15 | $194.51K derived: sum of 3 quarters · filed 2023-11-13 | $197.97K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $6.95K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $48.65K derived: sum of 2 quarters · filed 2023-11-13 | $52.11K derived: sum of 3 quarters · filed 2023-11-13 | $53.05K 10-K · filed 2023-03-27 |
| 2022-09-30 | $41.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $45.16K derived: sum of 2 quarters · filed 2023-11-13 | $46.10K 10-Q · filed 2023-11-13 | $46.10K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $3.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $4.40K 10-Q · filed 2023-08-14 | $4.40K derived: sum of 3 quarters · filed 2023-08-14 | $4.40K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $942.00 10-Q · filed 2023-05-15 | $942.00 derived: sum of 2 quarters · filed 2023-05-15 | $942.00 derived: sum of 3 quarters · filed 2023-05-15 | $942.00 derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $0.00 derived: sum of 2 quarters · filed 2023-03-27 | $0.00 derived: sum of 3 quarters · filed 2023-03-27 | $450.00K 10-K · filed 2023-03-27 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $450.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $450.00K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $450.00K 10-Q · filed 2022-05-13 | |||
| 2020-06-30 | $11.25M 10-Q · filed 2021-08-13 |